Photo: <a href="https://depositphotos.com" target="_blank">Depositphotos</a>
Sep 20, 2025, 13:58
Novo Nordisk Haemophilia Foundation Partners Drive Global Progress in Low-Dose Prophylaxis and Carrier Awareness
Novo Nordisk Haemophilia Foundation has shared a post on LinkedIn:
“NNHF Partners Highlight Meeting
We had an incredible session with strong engagement from 75 participants, featuring three powerful keynotes and fantastic engagement from our global partners. Your contributions made this virtual meeting truly impactful!
Key notes from our partners:
- South Africa – Dr Yasmin Goga and Molly Ndebele spoke about advocating for low-dose prophylaxis (vs. on-demand treatment) in low-resource settings, and highlighted the critical role of nurses in making this approach possible.
- Latin America – Yuri Arango highlighted important work with Carrier Women with Bleeding Disorders, driving awareness and better care pathways.
These discussions show what’s possible when we learn from each other and work together.
Are you a partner and want to join our next session? Stay tuned for the next invitation coming in February 2026!”
Stay informed with Hemostasis Today.
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities
-
Feb 22, 2026, 09:12Arun V J։ The Hidden Risks in Every Blood Bag
-
Feb 22, 2026, 08:56Parandzem Khachatryan։ How Hard Is It to Be a Mom, a Wife, a Professor, and a Doctor All at Once?
-
Feb 22, 2026, 08:46Anirban Sen Gupta Presents Bioinspired Platelet Surrogates at MTEC
-
Feb 22, 2026, 08:31Heghine Khachatryan: Advancing Care for Women and Girls with Bleeding Disorders is A Matter of Equity